Baker McKenzie advised Hysata on the deal. Hysata finalized a landmark Series B fundraising, raising a total of A$172 million (US$111 million) from a range of...
Hysata’s Series B Fundraising
URBNSURF’s Development of a Wave Park
Baker McKenzie assisted URBNSURF on the deal. URBNSURF develop Sydney’s first wave park, after opening Australia’s first wave park in Melbourne in 2020. Located just 13...
Olayan Financing Company’s Acquisition of a Stake in ICD Brookfield Place
Baker McKenzie advised the Olayan Financing Company on the deal. Olayan Financing Company finalized the acquisition of a 24.5% stake in ICD Brookfield Place (ICDBP), the...
Brenntag’s Acquisition of Quimica Delta in Mexico
Baker McKenzie advised Brenntag on the deal. Brenntag, the leading chemicals and ingredients distributor finalized the acquisition of Quimica Delta, a Mexican-based distributor of chemicals operating...
Niagara Energy’s USD 2.1 Billion Credit Facility
Estudio Echecopar, member of Baker & Mckenzie Internacional, advised the lenders in the transaction. The credit facility of USD 2.1 billion was granted to Niagara Energy...
Banco Falabella’s US$16 Million Certificates of Deposit Issuance
Estudio Echecopar, member firm of Baker Mckenzie International advised Scotiabank Perú S.A.A., as arranger, and Scotia Sociedad Agente de Bolsa S.A., as placement agent, in the...
JSC Bank of Georgia’s Additional Tier 1 Issuance
Baker McKenzie advised JSC Bank of Georgia on the deal. Bank of Georgia Group PLC’s banking subsidiary, JSC Bank of Georgia, secured the issuance of USD...
Harvest Global Investments Limited’s Listing of Harvest Bitcoin Spot ETF and Harvest Ether Spot ETF
Baker McKenzie assisted Harvest Global Investments Limited (HGI) on the deal. Harvest Global Investments Limited (HGI) secured the authorisation and successful listing of Harvest Bitcoin Spot...
Abu Dhabi National Insurance Company’s Acquisition of Shares in Allianz Saudi Fransi Cooperative Insurance
Baker McKenzie advised Allianz Group on the deal. Allianz Group, one of the world’s leading insurers and asset managers, completed the sale of its 51% shareholding...
CureVac’s Collaboration with MD Anderson
Baker McKenzie advised CureVac N.V. on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), entered into a...
DocMorris’s CHF200 Million Convertible Bonds Offering
Advestra acted as legal counsel to Goldman Sachs and UBS. Baker McKenzie advised DocMorris. DocMorris (former Zur Rose Group) successfully placed CHF 200 million senior unsecured...
Nobia’s Rights Offering
Baker McKenzie legal advisor to the banks. Nobia AB (publ) has carried out a fully guaranteed preferential rights issue of shares of approximately SEK 1,262 million...